Kirsty Gallacher, 50, revealed on Channel 5's Vanessa programme that she is awaiting an MRI scan to gauge the success of radiotherapy for her acoustic neuroma. The tumour, located in her inner ear canal, was treated last year and the scan will determine whether the growth has been controlled.

Radiotherapy Targeted at a 2021‑Diagnosed Acoustic Neuroma

Gallacher was diagnosed in 2021 after waking with sudden hearing loss in her right ear, an episode doctors treated as a possible emergency. The subsequent scans identified a non‑cancerous acoustic neuroma, which doctors deemed inoperable due to its proximity to critical nerves. As the source reported, radiotherapy was chosen to shrink the tumour and neutralise the DNA that fuels its growth.

Hearing Loss and Tinnitus Intensify After Treatment

The presenter disclosed that the radiotherapy has worsened her right‑ear hearing loss and increased the ringing sensation known as tinnitus. She now relies on lip‑reading in noisy settings and has not yet adopted a hearing aid, despite medcial advice. This personal account highlights the trade‑off many patients face between tumour control and quality‑of‑life side effects.

Everyday Challenges: Noise Overload and Social Withdrawal

Gallacher described how ordinary environments like restaurants have become overwhelming, forcing her to leave when background noise spikes. The source notes that such sensory overload is a common but under‑reported issue for acoustic‑neuroma patients, underscoring the invisible burden of hearing impairment.

What the Upcoming MRI Could Reveal

The imminent MRI is described as a “critical milestone” by Gallacher herself. If the scan shows tumour shrinkage, it would confirm the radiotherapy’s efficacy; if not, further treatment options may need to be explored. As the report states, the goal of therapy is control rather than elimination, a nuance often missed in public discussions of brain tumours.

Who Is Still Unclear About Long‑Term Outlook?

While Gallacher has spoken openly about her experience, the source does not provide expert commentary on the typical prognosis for acoustic neuromas after radiotherapy. it also leaves unnswered whether a hearing aid will eventually become part of her management plan, and how long the side effects might persist.